Nurix reports a USD 7 million milestone: what it means for Nurix Therapeutics stock

Published on 10/05/2026 at 13:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nurix reported a USD 7 million Pfizer milestone on September 29, 2026. For Nurix Therapeutics stock, second-quarter revenue was USD 9.04 million.

NRIX, US67080M1036, Illustration mit AI erstellt.

Nurix Therapeutics, Inc. (ISIN US67080M1036) reported a USD 7.00 million milestone payment from its Pfizer collaboration on September 29, 2026, bringing cumulative payments from the partnership to USD 82.00 million, according to Investing.com. The payment gives Nurix a concrete commercial milestone while its drug pipeline remains the central valuation driver.

Milestone adds partnership cash

The USD 7.00 million payment is part of Nurix's collaboration activity with Pfizer. The September 29, 2026 update also put cumulative Pfizer collaboration payments at USD 82.00 million, a figure that provides scale for the partnership's financial contribution.

Nurix is a clinical-stage biotechnology company focused on targeted protein degradation. Its collaboration portfolio includes programs with large pharmaceutical partners, while the company continues to fund research and clinical development.

Quarterly loss remains material

Nurix reported second-quarter 2026 revenue of USD 9.04 million, compared with analyst expectations of USD 15.29 million, according to MarketBeat. The company posted an adjusted loss of USD 0.81 per share against a consensus loss of USD 0.73, making the revenue shortfall and earnings miss important counterweights to the milestone.

The second-quarter figures show why partnership payments matter to the investment case. Revenue was USD 6.25 million in the first quarter of 2026 and rose to USD 9.04 million in the second quarter, while the quarterly net loss widened from USD 87.17 million to USD 89.54 million.

Market value and next report

Nurix had a market capitalization of USD 2.4 billion as of October 2, 2026. Its 52-week range was USD 9.00 to USD 28.23, leaving a USD 19.23 spread between the low and high. The next earnings date is October 9, 2026, according to Investing.com.